Please login to the form below
AZ's Mene Pangalos joins Precision Medicine Catapult board
Has also been appointed a fellow at the University of Cambridge
AstraZeneca's Mene Pangalos, executive VP of IMED Biotech, has been appointed in two new positions based in Cambridge.
Pangalos will join the board of the Precision Medicine Catapult, the newly established centre in Cambridge designed to shape the future of precision medicine in the UK.
In his role as non-executive director, Pangalos will provide a pharmaceutical industry perspective on how to ensure the UK can remain at the cutting edge of precision medicine.
Additionally, Pangalos has also been appointed an as official fellow of Clare Hall College in the University of Cambridge.
Pangalos said: “I'm delighted to receive these two appointments. Although they are a great personal honour, I believe they are testament to the quality of our science, our pioneering approach to personalised healthcare and our long standing commitment to strengthening the UK life science sector.”
Subscribe to our email news alerts
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- How an AI algorithm might save your life
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Genesis Research
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
